Glutamine and Mesalamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glutamine (glutamine) and Mesalamine (mesalamine). Common drug interactions include pyrexia among females and liver injury among males.

The phase IV clinical study analyzes what interactions people have when they take Glutamine and Mesalamine. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Glutamine?

Glutamine has active ingredients of glutamine. It is often used in muscle building therapy. eHealthMe is studying from 2,705 Glutamine users. Check the latest studies of Glutamine.

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.



On Jul, 12, 2026

42 people who take Glutamine and Mesalamine together, and have interactions are studied.

Glutamine and Mesalamine drug interactions.

What are the common drug interactions of Glutamine and Mesalamine, by gender? *:

female:

  1. Pyrexia (fever)
  2. Salpingo-oophoritis (inflammation of a uterine tube and ovary)
  3. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
  4. Hepatitis c
  5. Anastomotic fistula
  6. Female reproductive neoplasm (tumour of uterus ,fallopian tube ,or cervix)
  7. Intestinal fistula
  8. Fatigue (feeling of tiredness)
  9. Hypokalaemia (low potassium)
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Liver injury
  2. Eosinophilic oesophagitis (allergic inflammatory condition of the oesophagus)
  3. Lower limb fracture
  4. Megacolon (a very dilated colon)
  5. Renal injury (kidney injury)
  6. Intestinal obstruction
  7. Pulmonary tuberculosis (lungs tuberculosis)
  8. Tuberculosis (a bacterial infection by mycobacterium tuberculosis)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Anal haemorrhage

What are the common drug interactions of Glutamine and Mesalamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Arthralgia (joint pain)
  2. Abdominal pain upper
  3. Administration site pain
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Device related infection
  6. Diarrhoea haemorrhagic (bloody diarrhoea)
  7. Fatigue (feeling of tiredness)
  8. Gastrointestinal infection (infection of stomach and intestine)
  9. Impaired gastric emptying
  10. Intestinal obstruction

30-39:

  1. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
  2. Pyrexia (fever)
  3. Anal haemorrhage
  4. Intestinal obstruction

40-49:

  1. Anastomotic fistula
  2. Female reproductive neoplasm (tumour of uterus ,fallopian tube ,or cervix)
  3. Liver injury
  4. Eosinophilic oesophagitis (allergic inflammatory condition of the oesophagus)
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Hyperlipidaemia (presence of excess lipids in the blood)
  7. Intestinal fistula
  8. Intestinal polyp (small growths in the bowel with the potential for further growth)
  9. Productive cough
  10. Serum ferritin decreased

50-59:

  1. Lower limb fracture
  2. Gastritis (inflammation of stomach)
  3. Hepatic failure (liver failure)

60+:

  1. Hepatitis c
  2. Eosinophil count increased
  3. Hypokalaemia (low potassium)
  4. Pruritus (severe itching of the skin)
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the existing conditions these people have? *

  1. Inflammatory Bowel Disease: 26 people, 61.90%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 14 people, 33.33%
  3. Fever: 7 people, 16.67%
  4. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 6 people, 14.29%
  5. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 3 people, 7.14%
  6. Latent Tuberculosis (hidden tuberculosis): 3 people, 7.14%
  7. Haemoglobin Decreased: 3 people, 7.14%
  8. Diabetes: 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Glutamine and Mesalamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Glutamine and Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glutamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glutamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mesalamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on glutamine and mesalamine (the active ingredients of Glutamine and Mesalamine, respectively), and Glutamine and Mesalamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: